Instil Bio (TIL) Retained Earnings (2020 - 2026)
Instil Bio (TIL) posted quarterly Retained Earnings of -$532000.0 for Q1 2026, down 17.96% year-over-year from -$648464.9 in Q1 2025, and up 8.75% quarter-over-quarter from -$583000.0 in Q4 2025.
Instil Bio (TIL) Retained Earnings (2020 - 2026) Analysis & Trends
Instil Bio's Retained Earnings history runs 7 years deep, the most recent figure standing at -$532000.0 for Q1 2026.
- In Q1 2026, Retained Earnings fell 17.96% year-over-year to -$532000.0; the TTM figure through Mar 2026 stood at -$532000.0 (down 17.96% YoY), while the FY2025 annual figure was -$583000.0, up 99.91% from the prior year.
- Retained Earnings for Q1 2026 stood at -$532000.0, up from -$583000.0 in the prior quarter.
- The five-year high for Retained Earnings was $839.3 million in Q3 2025, with the low at -$655.1 million in Q4 2024.
- The 5-year median for Retained Earnings is -$557000.0 (2022), against an average of -$53.3 million.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings jumped 180036.96% in 2023, then plunged 122418.29% in 2024.
- Instil Bio's Retained Earnings stood at -$493000.0 in 2022, then plunged by 117746.04% to -$581.0 million in 2023, then retreated by 12.76% to -$655.1 million in 2024, then jumped by 99.91% to -$583000.0 in 2025, then rose by 8.75% to -$532000.0 in 2026.
- Business Quant data shows TIL's Retained Earnings at -$532000.0 in Q1 2026, -$583000.0 in Q4 2025, and $839.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - | 4.38 Bn |
| 10 | Instil Bio | 53.44 Mn | 53.44 Mn | - | 842.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 842.96 Mn |
| Mar 31, 2026 | -532,000.00 |
| Dec 31, 2025 | -583,000.00 |
| Sep 30, 2025 | 839.33 Mn |
| Jun 30, 2025 | 837.19 Mn |
| Mar 31, 2025 | -451,000.00 |
| Dec 31, 2024 | -655.12 Mn |
| Sep 30, 2024 | -643.22 Mn |
| Jun 30, 2024 | -620.20 Mn |
| Mar 31, 2024 | -563,000.00 |
| Dec 31, 2023 | -580.98 Mn |
| Sep 30, 2023 | -525,000.00 |
| Jun 30, 2023 | -500.62 Mn |
| Mar 31, 2023 | 793.52 Mn |
| Dec 31, 2022 | -493,000.00 |
| Sep 30, 2022 | -371.05 Mn |
| Jun 30, 2022 | -557,000.00 |
| Mar 31, 2022 | -441,000.00 |
| Dec 31, 2021 | -201.72 Mn |
| Sep 30, 2021 | 747.89 Mn |